Results 11 to 20 of about 12,603 (200)

Behavioral and metabolic effects of the atypical antipsychotic ziprasidone on the nematode Caenorhabditis elegans. [PDF]

PLoS ONE, 2013
Atypical antipsychotics are associated with metabolic syndrome, primarily associated with weight gain. The effects of Ziprasidone, an atypical antipsychotic, on metabolic syndrome has yet to be evaluated.
Priscila Gubert, Gabriel Costa Aguiar, Tácito Mourão, Jessika Cristina Bridi, Alexandre Guimarães Barros, Félix Alexandre Soares, Marco Aurélio Romano-Silva   +6 more
doaj   +1 more source

Significance of Ziprasidone Nanoparticles in Psychotic Disorders

Materials Proceedings, 2023
Nanotechnology is used today in a wide range of industries. Weakly water-soluble medications have better solubility and bioavailability when delivered by nano-specific drug delivery methods, such as nanocrystals.
Mamta Patil, Javesh Patil, Devyani Patil, Kiran Patel, Aayushi Tatiya   +4 more
doaj   +1 more source

Acne caused by ziprasidone in a young patient with bipolar disorder: A case report

Frontiers in Psychiatry, 2022
BackgroundZiprasidone is a second-generation antipsychotic drug commonly used to treat schizophrenia and bipolar disorder. Acne is a common inflammatory disease of sebaceous glands in adolescents that is often co-morbid with anxiety and depression, which
Yiwen Yuan, Yiwen Yuan, Xiaoqing Li, Xiaoqing Li, Xingmei Jiang, Xingmei Jiang, Zhixiong Li, Ying Ou, Ying Ou, Zhe Li, Zhe Li   +10 more
doaj   +1 more source

Drug eruption caused by ziprasidone： a case report

Sichuan jingshen weisheng, 2022
This paper reported a case of drug eruption in a male patient with first-episode schizophrenia. The patient received ziprasidone monotherapy， and experienced post-treatment remission of schizophrenic symptoms， while accompanied by drug eruption with ...
Hong Jiakun, Sun Yanbing, Liu Xiaobing
doaj   +1 more source

Retrospective Study of Midazolam Protocol for Prehospital Behavioral Emergencies [PDF]

, 2020
Introduction: Agitated patients in the prehospital setting pose challenges for both patient care and emergency medical services (EMS) provider safety. Midazolam is frequently used to control agitation in the emergency department setting; however, limited
Huebinger, Ryan M., Markul, Eddie, Pearlman, Kenneth S., Richards, Christopher T., Stein-Spencer, Leslee, Tataris, Katie L., Weber, Joseph M., Zaidi, Hashim Q.   +7 more
core   +1 more source

The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study

BMC Psychiatry, 2023
Background Ziprasidone mesylate injection is an atypical antipsychotic drug which is recently approved in China. In combination with its oral formulation, sequential therapy with ziprasidone brings new interventions to patients with agitation in the ...
Yaxue Wu, Yanli Li, Weiye Liang, Luyuan Bai, Jianjin Yu, Keqing Li, Yunshu Zhang, Yanmei Guo, Zenglong Liu, Jian Wang, Congpei Zhang, Xijin Wang, Jia Xu, Liping Liu, Juan Li, Fude Yang   +15 more
doaj   +1 more source

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial

Frontiers in Pharmacology, 2022
Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking.
Hui Shi, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang, Xiang Yang Zhang   +6 more
doaj   +1 more source

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database [PDF]

, 2013
Background: Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden. Objective: As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US ...
A Bate, A Clarke, A Pariente, AK Chung, Ariola Koci, B Darpo, BJ Drew, C Meyer-Massetti, DM Roden, DW Hough, E Poluzzi, E Poluzzi, E Poluzzi, E Raschi, E Raschi, Edoardo Spina, Elijah R. Behr, Elisabetta Poluzzi, Emanuel Raschi, EP Puijenbroek van, ER Behr, F Ponti De, F Ponti De, F Rani, Fabrizio De Ponti, GC Alexander, GK Isbister, H Verdoux, J Nielsen, J Papay, K Jolly, K Titier, LC Wittkampf, LS Schneider, Miriam Sturkenboom, NP Tatonetti, P Kannankeril, P Manu, P Vigneault, RC Owens Jr, RR Shah, S Dhillon, S Hennessy, S Kongsamut, S Leucht, SM Straus, Ugo Moretti, W Crumb, W Crumb, WA Ray, WA Ray, WJ Crumb Jr, WP Stephenson, Y Suzuki   +53 more
core   +4 more sources

Use of a New Ziprasidone-Selective Electrode in Mixed Solvents and Its Application in the Analysis of Pharmaceuticals and Biological Fluids

Sensors, 2011
The construction and characterization of a new ion-selective electrode for the determination of the antipsychotic ziprasidone in mixed solvents is presented. The electrode contains a plasticized polymeric membrane based on a ziprasidone-tetraphenylborate
María Cuartero, Mª Soledad García, Mustafa Salem Abuherba, Joaquín A. Ortuño   +3 more
doaj   +1 more source

Restless legs syndrome following the use of ziprasidone: a case report

General Psychiatry, 2020
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterised by an uncomfortable urge to move the legs that occurs during periods of inactivity.
Hui Zhou, Yezhe Lin, Cuizhen Zhu, Yuliang Hu, Ran Bi, Daomin Zhu, Brian Isaacson, Qingwei Li   +7 more
doaj   +1 more source